Table 5 Percent of private sector outlets who reportedly received government or non-governmental support, and among outlets who received a support strategy, type of support received
Private for-profit health facility | Pharmacy | Drug store | General retailer | Itinerant drug vendor | All private sector | |
|---|---|---|---|---|---|---|
% (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
N = 326 | N = 99 | N = 46 | N = 39 | N = 235 | N = 745 | |
Received any type of support | 60.2 (53.6, 66.4) | 71.7 (61.7, 80.0) | 45.5 (29.7, 62.2) | 3.2 (0.7, 13.8) | 25.5 (18.8, 33.6) | 44.4 (39.0, 49.9) |
Among outlets with support | N = 196 | N = 69 | N = 19 | N = 1 | N = 64 | N = 349 |
Report access to subsidized anti-malarials | 58.3 (49.2, 66.9) | 69.4 (58.7, 78.5) | 26.8 (13.3, 46.6) | 0.0 (–) | 55.7 (44.4, 66.5) | 57.5 (51.1, 63.7) |
Report access to subsidized RDT | 63.5 (54.0, 72.1) | 69.1 (58.9, 77.7) | 60.2 (36.4, 80.0) | 0.0 (–) | 58.6 (45.5, 70.7) | 63.0 (55.9, 69.6) |
Report received training in the past year on malaria diagnosis (RDT and/or microscopy) and/or the National treatment guidelines for malaria | 65.3 (57.1, 72.7) | 66.0 (53.2, 76.8) | 36.1 (18.0, 59.2) | 100.0 (–) | 42.6 (31.5, 54.4) | 59.1 (53.9, 64.2) |
Report receiving a supervisory or regulatory visit within the past year | 27.6 (21.7, 34.3) | 17.8 (8.9, 32.6) | 20.7 (5.5, 54.0) | 0.0 (–) | 8.6 (3.9, 18.0) | 21.4 (16.7, 27.0) |
Report keeping and reporting malaria caseload data to government or non-government organization | 50.3 (40.0, 60.6) | 22.2 (11.8, 37.9) | 18.0 (4.0, 53.4) | 0.0 (–) | 21.1 (11.7, 35.0) | 36.9 (27.8, 47.1) |